• 1
    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl. 2): II437.
  • 2
    Agreus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 67180.
  • 3
    Saito YA, Schoenfeld P, Locke GR III. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 19105.
  • 4
    Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983; 1: 6324.
  • 5
    Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 7882.
  • 6
    Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients’ description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 41521.
  • 7
    Svedlund J, Sjodin I, Dotevall G, Gillberg R. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Scand J Gastroenterol 1985; 20: 595601.
  • 8
    Dainese R, Galliani EA, De Lazzari F, Di Leo V, Naccarato R. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 18927.
    Direct Link:
  • 9
    Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001; 63: 10815.
  • 10
    Snape WJ Jr, Matarazzo SA, Cohen S. Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity. Gastroenterology 1978; 75: 3738.
  • 11
    Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology 1991; 101: 37381.
  • 12
    Wiley J, Tatum D, Keinath R, Owyang C. Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response. Gastroenterology 1988; 94: 11449.
  • 13
    Wright SH, Snape WJ Jr, Battle W, Cohen S, London RL. Effect of dietary components on gastrocolonic response. Am J Physiol 1980; 238: G22832.
  • 14
    Narducci F, Snape WJ Jr, Battle WM, London RL, Cohen S. Increased colonic motility during exposure to a stressful situation. Dig Dis Sci 1985; 30: 404.
  • 15
    Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut 1989; 30: 63441.
  • 16
    Sullivan MA, Cohen S, Snape WJ Jr. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. N Engl J Med 1978; 298: 87883.
  • 17
    Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB et al. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992; 67: 72531.
  • 18
    Musial F, Crowell MD, Kalveram KT, Enck P. Nutrient ingestion increases rectal sensitivity in humans. Physiol Behav 1994; 55: 9536.
  • 19
    Erckenbrecht JF, Hemstege M, Rühl A, Krause J. The sensory component of the gastrocolonic response revisited: postprandial colonic perception depends on meal composition. Gastroenterology 1994; 106: A494.
  • 20
    Simrén M, Abrahamsson H, Björnsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 48: 207.
  • 21
    Distrutti E, Hauer SK, Fiorucci S, Pensi MO, Morelli A. Intraduodenal lipids increase perception of rectal distension in IBS patients. Gastroenterology 2000; 118 (4, Suppl. 2): A138.
  • 22
    Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D et al. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol 2005; 100: 3839.
    Direct Link:
  • 23
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 24
    Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998; 274: G58490.
  • 25
    Lembo T, Munakata J, Naliboff B, Fullerton S, Mayer EA. Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig Dis Sci 1997; 42: 111220.
  • 26
    Kwan CL, Davis KD, Mikula K, Diamant NE. Abnormal rectal motor physiology in patients with irritable bowel syndrome. Neurogastroenterol Motil 2004; 16: 25163.
  • 27
    Lembo T, Munakata J, Mertz H, Niazi N, Kodner A, Nikas V et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107: 168696.
  • 28
    Simrén M, Castedal M, Svedlund J, Abrahamsson H, Björnsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Dig Dis Sci 2000; 45: 215161.
  • 29
    King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 11879.
  • 30
    Azpiroz F. Intestinal gas dynamics: mechanisms and clinical relevance. Gut 2005; 54: 8935.
  • 31
    Böhmer CJ, Tuynman HA. The clinical relevance of lactose malabsorption in irritable bowel syndrome. Eur J Gastroenterol Hepatol 1996; 8: 10136.
  • 32
    Jones VA, McLaughlan P, Shorthouse M, Workman E, Hunter JO. Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982; 2: 11157.
  • 33
    Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988; 95: 694700.
  • 34
    Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001; 48: 12531.
  • 35
    Tillander J, Ringström G, Björnsson E, Abrahamsson H, Simrén M. Do duodenal protein or carbohydrate affect colonic sensorimotor function in irritable bowel syndrome (IBS) and health? Gastroenterology 2002; 122 (4; Suppl. 1): T1333.
  • 36
    Ragnarsson G, Hallböök O, Bodemar G. Abdominal symptoms are not related to anorectal function in the irritable bowel syndrome. Scand J Gastroenterol 1999; 34: 2508.
  • 37
    Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004; 53: 11028.
  • 38
    Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998; 115: 126371.
  • 39
    Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Gutierrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med 1999; 26: 4049.
  • 40
    Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002; 97: 273843.
    Direct Link:
  • 41
    Meyer JH, Hlinka M, Kao D, Lake R, MacLaughlin E, Graham LS et al. Gastric emptying of oil from solid and liquid meals. Effect of human pancreatic insufficiency. Dig Dis Sci 1996; 41: 16919.
  • 42
    Accarino AM, Azpiroz F, Malagelada JR. Modification of small bowel mechanosensitivity by intestinal fat. Gut 2001; 48: 6905.
  • 43
    Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998; 12: 84955.
  • 44
    Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol 1997; 92: 20739.
  • 45
    Notivol R, Coffin B, Azpiroz F, Mearin F, Serra J, Malagelada JR. Gastric tone determines the sensitivity of the stomach to distention. Gastroenterology 1995; 108: 3306.
  • 46
    Simrén M, Simms L, D'Souza D, Abrahamsson H, Björnsson ES. Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5HT3-receptors. Aliment Pharmacol Ther 2003; 17: 27987.
  • 47
    Simrén M, Ringström G, Björnsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004; 66: 2338.
  • 48
    Feinle C, Grundy D, Otto B, Fried M. Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000; 278: R121723.
  • 49
    Kellow JE, Miller LJ, Phillips SF, Zinsmeister AR, Charboneau JW. Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome. Am J Physiol 1987; 253: G6505.
  • 50
    Roberts-Thomson IC, Fettman MJ, Jonsson JR, Frewin DB. Responses to cholecystokinin octapeptide in patients with functional abdominal pain syndromes. J Gastroenterol Hepatol 1992; 7: 2937.
  • 51
    Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988; 29: 123643.